(Hans) JL Severens

Full Professor Erasmus School of Health Policy & Management
Burg. Oudlaan 50, Rotterdam

More information

Back to overview


Since 2009 Hans Severens has been professor of Evaluation in Health Care at both ESHPM and the Institute of Medical Technology Assessment (iMTA; He holds an MSc in Policy and Management in Health Sciences from the Maastricht University, and a PhD from the Radboud University Nijmegen, the Netherlands. He was appointed previously as professor of Medical Technology Assessment at Maastricht University and co-head of the department of Clinical Epidemiology and Medical Technology Assessment of the University Hospital Maastricht.

Hans’ work focusses on economic evaluations of health care technologies, either as part of clinical trials or independent modelling studies and working on the research methods within this field. In this respect, he worked on the validity and reliability of cost measurement, productivity costs, statistics of incremental cost-effectiveness, the efficiency of implementation strategies and the international transferability of cost-effectiveness studies. In close collaboration with clinical researchers, he has been working on studies in a broad range of medical disciplines, such as rheumatology, oncology, infectious disease, rehabilitation, geriatrics, and psychiatry.

He organizes and teaches both full and short courses regarding the principles of economic evaluations. At ESHPM, he teaches within the bachelor of Health Sciences, the MSc-programmes Health Economics, Policy, and Law (HEPL) and EuHEM, a joint degree in health economics, policy, and management. He is chair of EuHEM, which is an Erasmus Mundus Joint Master Degree based on a collaboration with the universities of Oslo-Norway, and Bologna-Italy and the Management Centre Innsbruck-Austria.

Throughout his career, Hans has been actively involved in health care decision making. The past four years, he was vice-president of the Health Council of the Netherlands (Gezondheidsraad) and, as being a formal member of the Health Council, he still chairs the National Immunization Technology Advisory Group. From 2005 until 2014, he was member of the Committee ‘Farmaceutische Hulp’ (CFH) of the Health Care Insurance Board (CVZ), for drug reimbursement advice. Besides, he is former member of the Board of Directors of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and was co-editor of the scientific journal of this society, Value in Health, for 10 years. Over 250 peer-reviewed papers are on his list of publications and he currently holds a Hirsch index of 41.


Visiting address

Burg. Oudlaan 50 3062 PA Rotterdam

Postal address

Postbus 1738 3000 DR Rotterdam